Details

Heart failure in Europe : Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry
ID Lund, Lars H. (Author), ID Lainščak, Mitja (Author), et al.

.pdfPDF - Presentation file, Download (1,04 MB)
MD5: 01BDAC8D8A6F16DE14DFD86400F1F843
URLURL - Source URL, Visit https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3445 This link opens in a new window

Abstract
Aims: We analysed baseline characteristics and guideline-directed medical therapy (GDMT) use and decisions in the European Society of Cardiology (ESC) Heart Failure (HF) III Registry. Methods and results: Between 1 November 2018 and 31 December 2020, 10 162 patients with acute HF (AHF, 39%, age 70 [62-79], 36% women) or outpatient visit for HF (61%, age 66 [58-75], 33% women), with HF with reduced (HFrEF, 57%), mildly reduced (HFmrEF, 17%) or preserved (HFpEF, 26%) ejection fraction were enrolled from 220 centres in 41 European or ESC-affiliated countries. With AHF, 97% were hospitalized, 2.2% received intravenous treatment in the emergency department, and 0.9% received intravenous treatment in an outpatient clinic. AHF was seen by most by a general cardiologist (51%) and outpatient HF most by a HF specialist (48%). A majority had been hospitalized for HF before, but 26% of AHF and 6.1% of outpatient HF had de novo HF. Baseline use, initiation and discontinuation of GDMT varied according to AHF versus outpatient HF, de novo versus pre-existing HF, and by ejection fraction. After the AHF event or outpatient HF visit, use of any renin-angiotensin system inhibitor, angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist and loop diuretics was 89%, 29%, 92%, 78%, and 85% in HFrEF; 89%, 9.7%, 90%, 64%, and 81% in HFmrEF; and 77%, 3.1%, 80%, 48%, and 80% in HFpEF. Conclusion: Use and initiation of GDMT was high in cardiology centres in Europe, compared to previous reports from cohorts and registries including more primary care and general medicine and regions more local or outside of Europe and ESC-affiliated countries.

Language:English
Keywords:ejection fraction, guideline-directed medical therapy, heart failure, implementation, quality of care, registry
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 2487-2501
Numbering:Vol. 26, iss. 12
PID:20.500.12556/RUL-182442 This link opens in a new window
UDC:616.1
ISSN on article:1388-9842
DOI:10.1002/ejhf.3445 This link opens in a new window
COBISS.SI-ID:225964035 This link opens in a new window
Publication date in RUL:12.05.2026
Views:380
Downloads:190
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:European journal of heart failure
Shortened title:Eur. j. heart fail.
Publisher:Wiley, European Society of Cardiology
ISSN:1388-9842
COBISS.SI-ID:1217301 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:iztisni delež, s smernicami usmerjena medicinska terapija, srčno popuščanje, implementacija, kakovost oskrbe, register

Projects

Funder:Abbot Vascular Int.

Funder:Amgen Cardiovascular

Funder:AstraZeneca AB

Funder:Bayer AG

Funder:Boehringer Ingelheim

Funder:Bristol Myers Squibb

Funder:Daichii Sankyo Europe GmbH

Funder:Edwards Lifesciences

Funder:Novartis Pharma AG

Funder:Servier

Funder:Vifor

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back